Long-term observations of a patient with choroidal melanoma following fractionated stereotactic radiotherapy: a case report

K Tokuuye; M Sumi; Y Kagami; S Murayama; H Ikeda; A Kaneko; Y Akine

doi:10.1034/j.1600-0420.2000.078004477.x

Long-term observations of a patient with choroidal melanoma following fractionated stereotactic radiotherapy: a case report

Acta Ophthalmol Scand. 2000 Aug;78(4):477-9. doi: 10.1034/j.1600-0420.2000.078004477.x.

Authors

K Tokuuye¹, M Sumi, Y Kagami, S Murayama, H Ikeda, A Kaneko, Y Akine

Affiliation

¹ Radiation Oncology Division, The National Cancer Center Hospital, Tokyo, Japan.

PMID: 10990057
DOI: 10.1034/j.1600-0420.2000.078004477.x

Abstract

A 60-year-old man with choroidal melanoma was treated with fractionated stereotactic radiotherapy and followed for 6 years. During this period, the tumor has not changed in size, and the patient has experienced only a slight decrease in visual acuity. In this case, stereotactic radiotherapy appears to have been safe and effective and may also be a cost-effective alternative to particle or plaque therapy.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Choroid Neoplasms / diagnostic imaging
Choroid Neoplasms / pathology
Choroid Neoplasms / surgery*
Dose Fractionation, Radiation
Follow-Up Studies
Fundus Oculi
Humans
Magnetic Resonance Imaging
Male
Melanoma / diagnostic imaging
Melanoma / pathology
Melanoma / surgery*
Middle Aged
Radiosurgery / methods*
Tomography, X-Ray Computed
Treatment Outcome
Visual Acuity